Dr Reddy’s Lab receives US FDA approval to market Lenalidomide capsule Press Trust of India Oct 19, 2021 Dr Reddy's Laboratories today said it has received approval from the US health regulator to market Lenalidomide capsules
COVID-19 pushes up sales of cardiac, anti-diabetic drugs IANS Jul 18, 2020 The sudden change in preferred therapies by masses has just taken a sharp turn from pre-COVID period when gastric, vitamin…
Dr Reddy’s Labs launches generic injection indicated for abortion in US Press Trust of India Dec 9, 2019 The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market
